Myeloma: Treating Blood Cancer as a Chronic Disease

Click Here to Participate

Recorded on: April 28, 2023
1.5 CE Credit/Contact hours for nurses and social workers available until: January 14, 2025
1.5 CE Contact hours for nurse practitioners available until: July 31, 2024
ILNA Accredited
Format: Non-interactive recorded webinar 

 

Target Audience

This CE activity is intended for oncology nurses, social workers, and nurse practitioners involved in the care of patients with hematologic malignancies.

Description

Through interactive discussion and attendee feedback on patient cases, this symposium will provide an overview of FDA approved treatments and others being studied in clinical trials for myeloma, including oral therapy, systemic therapy, transplant, CAR T-cell therapy, and bispecific antibodies. The focus will be on the nurse’s role in administering treatment, side-effect management, educating and supporting patients, the role of the interdisciplinary team, and accessing resources for survivorship support. Disparities in diagnosis and treatment of Black Americans, low income, and other underserved populations, as well as issues that impede patients’ access to treatment will also be discussed. Attend this engaging, interactive, and fun symposium to learn more!

Learning Objectives

Upon completion, participants should be better able to:

• Identify disparities in diagnosing myeloma and access to treatment
• Explain treatment options and side-effect management, including newly approved and treatments in clinical trials
• Describe the factors to consider when initiating and/or changing treatment, including challenges in adherence to treatment for myeloma as a chronic blood cancer
• Explain goals of coordination among medical specialties to follow a plan of care throughout survivorship for myeloma and other chronic blood cancers
• List resources to support patients and their caregivers

Faculty

Krina K. Patel, MD, MSc
Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
 
Rhonda Hewitt, MSN, ANP, AOCNP
Hematology APP IV
Stanford Health Care
Stanford, CA

Continuing Education Information

Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

Nurse Practitioner Credit Designation
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23066199. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.5 clinical continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.5 clinical CE contact hours for this activity.

ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (ONC, CBCN, CPHON, AOCNP), Oncology Nursing Practice (ONC), Professional Practice/Performance (BMTCN, AOCNP), Psychosocial Dimensions of Care (AOCNP, CPHON, ONC, CBCN), Symptom Management, Palliative Care, Supportive Care (ONC, CPHON, AOCNP), Treatment (OCN, CBCN, AOCNP, CPHON). 
Total points: 1.5*
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.

Providers

This activity is provided by The Leukemia & Lymphoma Society.

There are no fees for participating in or receiving credit for this CE activity.

Method of Participation

In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest and evaluation form and your certificate of credit will be generated. 

There are no system requirements other than an internet connection.

Supporters

There is no commercial support associated with this CE activity.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.